IQVIA (IQV) slides as CRO sector sentiment sours ahead of earnings

IQVIA Holdings Inc. (IQV) is down 9.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The move looks primarily driven by a risk-off swing in contract research organization (CRO) stocks after a sharp selloff in a major peer following its quarterly update, which can reset investor expectations for near-term demand and backlog conversion across the group. Ongoing concerns that AI could change how biopharma companies run parts of clinical development also remain an overhang, keeping the sector volatile.

Details:

A large CRO peer’s shares fell sharply following its Q1 2026 update, even with results coming in above expectations, which appeared to pressure sentiment across the CRO group.

Recent sector commentary has highlighted investor fears that advances in AI could allow some trial-related work to be brought in-house, contributing to broad multiple compression in CRO names.

IQVIA’s most recent annual results included full-year 2026 guidance, which investors have previously treated cautiously versus Street expectations.

IQVIA has scheduled its next quarterly results release for May 5, 2026, which can amplify positioning-related moves in the weeks leading up to the report.

Sources:

IQVIA Investor Relations, Investing.com, Reuters

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$IQV Insider Trading Activity

$IQV insiders have traded $IQV stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $IQV stock by insiders over the last 6 months:

ARI BOUSBIB (See Remarks) has made 0 purchases and 7 sales selling 93,121 shares for an estimated $20,594,049.
ERIC SHERBET (See Remarks) sold 4,000 shares for an estimated $878,800

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

EARLY ACCESS

Receive IQV Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$IQV Hedge Fund Activity

We have seen 544 institutional investors add shares of $IQV stock to their portfolio, and 491 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 3,658,299 shares (-74.3%) from their portfolio in Q4 2025, for an estimated $824,617,177
CANADA PENSION PLAN INVESTMENT BOARD removed 2,412,144 shares (-58.6%) from their portfolio in Q4 2025, for an estimated $543,721,379
VICTORY CAPITAL MANAGEMENT INC added 1,614,063 shares (+2628.1%) to their portfolio in Q4 2025, for an estimated $363,825,940
NORDEA INVESTMENT MANAGEMENT AB removed 1,600,906 shares (-69.2%) from their portfolio in Q4 2025, for an estimated $360,860,221
FARALLON CAPITAL MANAGEMENT LLC removed 938,551 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $211,558,780
ORBIS ALLAN GRAY LTD added 933,554 shares (+96.5%) to their portfolio in Q4 2025, for an estimated $210,432,407
1832 ASSET MANAGEMENT L.P. added 769,074 shares (+47067.0%) to their portfolio in Q4 2025, for an estimated $173,356,970

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$IQV Congressional Stock Trading

Members of Congress have traded $IQV stock 2 times in the past 6 months. Of those trades, 1 have been purchases and 1 have been sales.

Here’s a breakdown of recent trading of $IQV stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $100,000 on 03/16.
SENATOR MARKWAYNE MULLIN purchased up to $50,000 on 12/29.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.

$IQV Analyst Ratings

Wall Street analysts have issued reports on $IQV in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Truist Securities issued a "Buy" rating on 01/08/2026
UBS issued a "Buy" rating on 01/08/2026
BMO Capital issued a "Outperform" rating on 11/13/2025
Baird issued a "Outperform" rating on 10/29/2025
Stifel issued a "Buy" rating on 10/29/2025

To track analyst ratings and price targets for $IQV, check out Quiver Quantitative's $IQV forecast page.

$IQV Price Targets

Multiple analysts have issued price targets for $IQV recently. We have seen 13 analysts offer price targets for $IQV in the last 6 months, with a median target of $225.0.

Here are some recent targets:

Elizabeth Anderson from Evercore ISI Group set a target price of $185.0 on 04/08/2026
Charles Rhyee from TD Cowen set a target price of $213.0 on 03/09/2026
Luke Sergott from Barclays set a target price of $210.0 on 03/06/2026
Ryan Halsted from RBC Capital set a target price of $221.0 on 03/03/2026
Jailendra Singh from Truist Securities set a target price of $245.0 on 02/19/2026
Shlomo Rosenbaum from Stifel set a target price of $220.0 on 02/06/2026
Patrick Donnelly from Citigroup set a target price of $200.0 on 02/06/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.